Bedside Snapshot
- Normal (Adult)
- <500 ng/mL FEU (<500 µg/L; 0.50 mg/L FEU). Over 50: age × 10 ng/mL FEU. DDU assays read about half; use the lab cutoff
- Critical Values
- No universal critical value: interpret by trend and clinical context. Very high with falling platelets and fibrinogen: score for DIC
- High Suggests
- PE, DVT, other venous thrombosis
- DIC, sepsis, trauma, recent surgery
- Aortic dissection, mesenteric ischemia, cancer
- Pregnancy, older age, recent fibrinolytic
- Low Suggests
- Below threshold with low or intermediate pretest probability and no anticoagulation: VTE effectively excluded. Otherwise rarely meaningful
- Act Now If
- Suspected PE with shock or refractory hypoxia: skip the D-dimer, resuscitate, activate your PE pathway. High pretest probability: image; a negative D-dimer cannot exclude PE
- Watch Out For
- Applying a D-dimer to high-probability, anticoagulated or post-lysis patients, or mixing FEU and DDU: the rule-out fails
Reference & Critical Ranges
Lab-specific ranges: Every lab sets its own range, by analyzer and by population. Use the range printed on your report. The values below are typical.
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adult (FEU assay) | <500 ng/mL FEU | <500 µg/L FEU (<0.50 mg/L FEU) | Usual venous thromboembolism (VTE) exclusion cutoff for quantitative, high-sensitivity assays; assay-specific |
| Adult (DDU assay) | About half the FEU number | Lab cutoff | D-dimer units (DDU) vs fibrinogen equivalent units (FEU) differ by a factor of about 2; use the lab's validated cutoff, never convert at the bedside |
| Older adult (>50 y) | Age × 10 ng/mL FEU | Age × 10 µg/L FEU | Age-adjusted cutoff for suspected pulmonary embolism (PE), validated with FEU assays: 75 years → <750 ng/mL FEU |
| Pregnancy | Rises as pregnancy advances | — | No trimester-specific rule-out cutoff; use the pregnancy-adapted YEARS thresholds (500 or 1000 ng/mL FEU) |
| Children | Lab-specific | Lab-specific | No validated VTE rule-out threshold; adult decision rules are not validated under 18 years |
Severity & critical values
| Level | Conventional | SI | What it means / typical findings |
|---|---|---|---|
| Below standard cutoff | <500 ng/mL FEU | <500 µg/L FEU | Low or intermediate pretest probability, no anticoagulation: PE and deep vein thrombosis (DVT) effectively excluded |
| Below age-adjusted cutoff | 500 to <age × 10 ng/mL FEU | 500 to <age × 10 µg/L FEU | Age >50, non-high PE probability: PE excluded without imaging |
| YEARS, no items | <1000 ng/mL FEU | <1000 µg/L FEU | PE excluded (YEARS and pregnancy-adapted YEARS) |
| Above the applicable cutoff | ≥ cutoff used | ≥ cutoff used | Positive: image (CT pulmonary angiography [CTPA] or ventilation-perfusion [V/Q] scan for PE, compression ultrasound for DVT). Not diagnostic |
| Markedly raised | >3× or >7× the upper limit | Same | Scores 2 or 3 points in the 2025 International Society on Thrombosis and Haemostasis (ISTH) overt disseminated intravascular coagulation (DIC) score |
| Critical | No universal value | No universal value | Interpret by pretest probability, trend and the rest of the coagulation panel |
Critical values: There is no universal critical value for D-dimer. Very high, with falling platelets and fibrinogen and a prolonged PT? Think DIC. A positive result in suspected PE needs imaging. Don't repeat the D-dimer.
Conversion: 1 ng/mL = 1 µg/L; 500 ng/mL = 0.50 mg/L = 0.50 µg/mL. FEU ≈ 2 × DDU (approximate and assay-specific).
Age-adjusted D-dimer cutoff (FEU assays, age >50)
Cutoff (ng/mL FEU) = age (years) × 10
Age 72? Negative below 720 ng/mL FEU (0.72 mg/L FEU).
Causes of Abnormal Results
Positive means above whichever cutoff you applied: standard, age-adjusted or YEARS. It shows one thing only. Cross-linked fibrin is being formed and lysed somewhere.
High (above the applicable cutoff)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Venous thrombosis | Pulmonary embolism, deep vein thrombosis; cerebral venous or splanchnic thrombosis | Pleuritic pain, dyspnea, tachycardia, hypoxia, unilateral leg swelling; headache or seizure (cerebral) |
| Consumptive coagulopathy | DIC from sepsis, trauma, obstetric catastrophe or malignancy | Oozing and bleeding, falling platelets and fibrinogen, prolonged PT |
| Arterial and aortic | Acute aortic dissection, acute mesenteric ischemia, aortic aneurysm | Tearing pain or pulse deficit; abdominal pain out of proportion to the exam |
| Tissue injury and bleeding | Trauma, recent surgery, large hematoma or internal hemorrhage | History; values stay raised while the wound or hematoma remodels |
| Infection and inflammation | Sepsis, pneumonia, COVID-19 | Fever, raised lactate; D-dimer tracks severity, not clot |
| Malignancy | Solid tumors and hematologic cancers | Known cancer; fewer patients fall below the cutoff |
| Physiologic and chronic | Pregnancy, older age, cirrhosis, sickle cell disease | Expected baseline rise lowers specificity |
| Drug effect | Fibrinolytics (alteplase, tenecteplase) | Recent lysis: the result cannot be used to exclude VTE |
Not a dissection rule-out: Acute aortic dissection usually raises D-dimer. The PE thresholds were never built to exclude it. If the story points to dissection, follow your aortic imaging pathway, whatever the D-dimer says.
Low (below the applicable cutoff)
A low D-dimer means something only as a rule-out. And it holds only when its assumptions hold. A real clot can still test low in these settings:
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Clot no longer being lysed | Long delay between symptom onset and testing | Long-standing leg or chest symptoms; the D-dimer may already have cleared |
| Anticoagulation | Therapeutic heparin, low-molecular-weight heparin or a direct oral anticoagulant (DOAC) for more than 24 hours | Check the medication list and administration record before you interpret |
| Small or excluded clot | Isolated calf (distal) or upper-extremity DVT | Some assays are not cleared for these; image if suspected |
| Low-sensitivity method | Qualitative or point-of-care whole-blood assays | Confirm which assay produced the result |
Interpretation & Bedside Approach
Step-by-step approach
- Is the patient unstable? Hypotension, shock or refractory hypoxia with suspected PE: skip the D-dimer, resuscitate and go straight to your PE pathway and imaging.
- Estimate pretest probability first. Use gestalt, the Wells score or the revised Geneva score. High probability (Wells PE >6, revised Geneva high, or gestalt high): image, because a D-dimer cannot exclude PE. For suspected DVT, a two-level Wells DVT score of 2 or more means DVT likely: go straight to compression ultrasound without a D-dimer.
- Very low gestalt (under 15%)? Apply the Pulmonary Embolism Rule-out Criteria (PERC). If all 8 criteria are met, stop: no D-dimer and no imaging. PERC replaces the D-dimer; it is not combined with it.
- Otherwise order a quantitative, high-sensitivity D-dimer and apply one validated threshold: age-adjusted (age × 10 ng/mL FEU over 50) or YEARS (1000 or 500 ng/mL FEU).
- Check the assumptions. FEU vs DDU, no therapeutic anticoagulation for more than 24 hours, no fibrinolytic within the previous 7 days, not pregnant (use pregnancy-adapted YEARS).
- Act on the result. Below threshold: VTE excluded, look for another diagnosis. Above threshold: CTPA (or V/Q) for PE, compression ultrasound for DVT. A positive D-dimer alone never diagnoses VTE.
Wells score for PE
| Criterion | Points |
|---|---|
| Clinical signs of DVT (leg swelling, pain on palpation) | 3 |
| PE more likely than other diagnoses | 3 |
| Heart rate >100 bpm | 1.5 |
| Immobilization ≥3 days or surgery in the previous 4 weeks | 1.5 |
| Previous DVT or PE | 1.5 |
| Hemoptysis | 1 |
| Cancer | 1 |
Three-level scoring: under 2 is low, 2–6 is moderate, over 6 is high. Two-level: 4 or under means PE unlikely, over 4 means PE likely. Pathways disagree on which cut point triggers D-dimer testing.
PERC: all 8 must be met (only when gestalt is under 15%)
- Age <50 years; heart rate <100 bpm; SpO₂ ≥95%
- No hemoptysis; no estrogen use; no prior DVT or PE
- No unilateral leg swelling
- No surgery or trauma requiring hospitalization in the prior 4 weeks
YEARS algorithm
| YEARS items present | PE excluded if D-dimer | Otherwise |
|---|---|---|
| None | <1000 ng/mL FEU | CTPA |
| One or more | <500 ng/mL FEU | CTPA |
The YEARS items are clinical signs of DVT, hemoptysis, and PE as the most likely diagnosis. The rule was studied only in patients not on therapeutic anticoagulation.
Some pathways use the PEGeD strategy instead. It pairs the Wells category with a D-dimer threshold. Like YEARS and the age-adjusted cutoff, it depends on protocol. Use the thresholds your pathway specifies.
D-dimer in DIC (2025 ISTH overt DIC score)
Over 3× the upper limit of normal, D-dimer scores 2 points. Over 7×, it scores 3. Platelets under 100 score 1, and under 50 ×10³/µL score 2. PT prolonged 3 to under 6 s scores 1, and 6 s or more scores 2. Fibrinogen under 100 mg/dL scores 1. A total of 5 or more is consistent with overt DIC. Score it only when an underlying cause is present, and repeat it. The trend matters more than any single score.
High probability means imaging: In a high-probability patient, a negative D-dimer does not exclude PE. A positive one adds nothing. Ordering it only delays imaging and anticoagulation.
Field & Transport Considerations
Point-of-care testing
Whole-blood point-of-care devices show up in some clinics, EDs and services. Against lab assays, they are more specific and less sensitive. Quantitative assays beat qualitative ones on sensitivity. Only cleared, clinically validated assays should be used to exclude PE, under your medical director's protocol. Never let a D-dimer downgrade a patient who looks sick.
Before and during interfacility transport
| Setting | Consideration |
|---|---|
| Field assessment | Record the PERC and Wells items: initial SpO₂ and heart rate, estrogen use, recent surgery or immobilization, prior VTE, hemoptysis, unilateral leg swelling. Never withhold oxygen to obtain a room-air reading. |
| Before transfer | Send the D-dimer value with its units (FEU or DDU), the cutoff used, the time drawn and the time of the first anticoagulant dose. |
| Confirmed PE en route | A D-dimer has no role after imaging confirms PE; monitor perfusion, oxygenation and bleeding, not the D-dimer. |
Timing & Kinetics
| Parameter | Value | Clinical implication |
|---|---|---|
| Formation | Whenever cross-linked fibrin is being lysed | Raised at presentation of acute VTE; draw at the first evaluation |
| Half-life | About 8 hours | Levels fall once active fibrinolysis slows; a long delay from symptom onset can produce a false negative |
| Therapeutic anticoagulation | Validation studies excluded patients anticoagulated within 24 hours | Draw before the first heparin or DOAC dose; after 24 hours of therapy a negative result cannot exclude VTE |
| Fibrinolytic therapy | Rises as existing clot is lysed | Uninterpretable for VTE exclusion within 7 days of alteplase or tenecteplase (Labcorp labeling) |
| Pregnancy | Rises as gestation advances | Pregnancy-adapted YEARS avoided CTPA in 65% in the first trimester vs 32% in the third |
| Specimen stability | Lab-specific; often 4 to 8 hours at room temperature or refrigerated (Labcorp: 8 hours) | Send promptly and follow your lab's limits |
| Repeat testing | Not useful once VTE is confirmed | Do not trend the D-dimer to judge anticoagulation; DIC is the exception (serial scoring) |
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates & infants | Age-specific ranges; no validated VTE rule-out threshold | Do not apply adult cutoffs; image when thrombosis is suspected |
| Children & adolescents | PERC, Wells, YEARS and age-adjustment were derived in adults (guidance covers ≥18 years); some assays are labeled not for pediatric use | A negative D-dimer does not exclude VTE; image if suspected |
| Pregnancy | Rises through gestation, lowering specificity | Pregnancy-adapted YEARS: compression ultrasound first if leg symptoms (positive scan → treat, no CTPA); otherwise YEARS thresholds 1000 or 500 ng/mL FEU |
| Older adults | Baseline rises with age | Use age × 10 ng/mL FEU over 50: in patients ≥75 it raised the share excluded without CT from 6.4% to 29.7% with no extra missed PE |
| Cancer, hospitalized, postoperative | More positive results from the underlying disease | A negative result is still valid with a validated strategy; positives need imaging |
| On anticoagulation, suspected recurrent PE | Levels suppressed by therapy | A normal D-dimer may support excluding recurrence; a raised one is not diagnostic on its own |
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Underfilled citrate tube | Unreliable | Blood-to-citrate ratio must be 9:1 | Fill the light-blue top to the line; adjust citrate if hematocrit is very high |
| Gross hemolysis or clotted sample | Unreliable | Hemolysis is the most common hemostasis interference; mild hemolysis is usually tolerated | Clean venipuncture, gentle handling; redraw if rejected |
Medications & supplements
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Therapeutic anticoagulation >24 hours | False − | Less new fibrin to lyse | Draw before the first dose; do not use for exclusion afterwards |
| Recent fibrinolytic | ↑ | Lysis of existing clot releases D-dimer | Do not use for VTE exclusion |
Physiologic / biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Rheumatoid factor, heterophile antibodies | False + | Bridge the assay antibodies | Lab can add blocking agents or run a second assay |
| Monoclonal gammopathy | Spurious | Paraprotein interference reported | Flag to the lab if a myeloma patient's result does not fit |
| Lipemia | Variable | Some immunoturbidimetric assays are affected at low concentrations | Lab may high-speed centrifuge; interpret near-cutoff values with care |
Assay & device-specific
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| FEU vs DDU | 2-fold error | DDU numbers are about half of FEU | Read the unit on the report before applying any threshold |
| Unit magnitude | 1,000-fold error | Reports use ng/mL, µg/L, mg/L or µg/mL | 0.50 mg/L FEU = 500 ng/mL FEU |
| Qualitative or point-of-care assay | False − | Lower sensitivity than quantitative lab assays | Use a validated quantitative assay for rule-out |
| Age-adjusted cutoff | Off-label use | May fall outside an assay's FDA-cleared intended use | Use only if your lab and pathway endorse it |
Common misinterpretations
- "Positive means PE": Most positive results are not VTE. Imaging decides.
- "Negative, so no PE" in a high-probability patient: The rule-out works only when pretest probability is low or intermediate.
- "Very high, so DIC": DIC needs a cause, plus platelets, PT and fibrinogen.
Physiology & Test Basics
What it measures
D-dimer is a family of breakdown products from cross-linked fibrin. Plasmin releases them when it breaks down a clot. It needs both steps, clot formation and clot breakdown, so it marks active thrombosis and fibrinolysis anywhere in the body. Small amounts are normal.
Physiology & regulation
- Thrombin turns fibrinogen into fibrin, and fibrin polymerizes.
- Factor XIIIa cross-links the D domains of neighboring fibrin molecules. That stabilizes the clot.
- Tissue plasminogen activator and urokinase generate plasmin. Plasmin then cleaves the cross-linked fibrin.
- The smallest product carries two cross-linked D domains. That is the D-dimer epitope. Breaking down fibrinogen alone never makes it.
- The circulating half-life is about 8 hours. Levels fall once active lysis stops.
How it is measured
Draw it in a light-blue top (3.2% sodium citrate), filled to the line. The lab tests the citrated plasma. Most laboratories run automated latex-enhanced immunoturbidimetric or enzyme-linked fluorescent immunoassays. Point-of-care devices test whole blood. No fasting is needed. Each assay has its own antibodies, calibrator and unit, FEU or DDU, so results from different assays are not interchangeable. The FDA expects a rule-out assay to reach at least 95% sensitivity and 97% negative predictive value.
Why it matters
Paired with a pretest probability tool, a negative D-dimer safely excludes PE or DVT. It spares many patients a CT, with its radiation and contrast. Used without a tool, it drives unnecessary imaging. In critical care, it is also part of DIC scoring.
Clinical Pearls
PERC before the tube: Gestalt under 15%, and all 8 PERC criteria met? Stop there. Ordering a D-dimer anyway risks a false positive and an unneeded CT.
Age-adjust over 50: Use age × 10 ng/mL FEU. The miss rate stays low, and far more older patients skip the CT. Check that your assay reports FEU and that your lab backs the cutoff.
Prehospital handoff: The ED will score these, so hand them off: first SpO₂ and heart rate, estrogen use, recent surgery or immobilization, prior VTE, hemoptysis and unilateral leg swelling. They settle whether a D-dimer is needed at all.
Nursing: tube and timing: Draw it before the first anticoagulant dose, and fill the light-blue top to the line. Record the dose time on the requisition or in the handoff.
Pregnancy is not an automatic CT: In pregnancy, a positive leg ultrasound under pregnancy-adapted YEARS leads straight to treatment. A D-dimer under the YEARS threshold excludes PE without imaging in many patients, most often early in pregnancy.
Units cause real errors: Same result, two names: 0.5 mg/L and 500 ng/mL. A DDU number runs about half its FEU equivalent. Check the unit before you use 500, 1000 or age × 10.
References
- Lim, W., Le Gal, G., Bates, S. M., et al. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: Diagnosis of venous thromboembolism. Blood Advances, 2(22), 3226–3256. https://doi.org/10.1182/bloodadvances.2018024828
- Righini, M., Van Es, J., Den Exter, P. L., et al. (2014). Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: The ADJUST-PE study . JAMA, 311(11), 1117–1124. https://doi.org/10.1001/jama.2014.2135
- van der Hulle, T., Cheung, W. Y., Kooij, S., et al. (2017). Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): A prospective, multicentre, cohort study. The Lancet, 390(10091), 289–297. https://doi.org/10.1016/S0140-6736(17)30885-1
- van der Pol, L. M., Tromeur, C., Bistervels, I. M., et al. (2019). Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism. New England Journal of Medicine, 380(12), 1139–1149. https://doi.org/10.1056/NEJMoa1813865
- Iba, T., Levy, J. H., Maier, C. L., et al. (2025). Updated definition and scoring of disseminated intravascular coagulation in 2025: Communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation. Journal of Thrombosis and Haemostasis, 23(7), 2356–2362. https://doi.org/10.1016/j.jtha.2025.03.038
- Wauthier, L., Favresse, J., Hardy, M., et al. (2022). D-dimer testing in pulmonary embolism with a focus on potential pitfalls: A narrative review. Diagnostics, 12(11), 2770. https://doi.org/10.3390/diagnostics12112770
- Labcorp. (2026). D-Dimer (test 115188): Specimen requirements, limitations and interpretation. Labcorp test menu (accessed October 2026). https://www.labcorp.com/test-menu/23851/d-dimer
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.